The Building Blocks of CAR T-cell Clinical Trials : Episode 10
Final Thoughts
The future of CAR T-cell therapies will continue to improve as they expand to other patients in need.
Video 10- Future part 2
Video Player is loading.
The panelists provide their closing thoughts on CAR T-cell therapies and what they look forward to as these therapies become popular beyond cancer, extending to autoimmune diseases as well. There is hope to remove manufacturing bottleneck so patient demand and access can improve.
Recent Videos
Looking Towards the Future of CAR T-cell Trials
Patient Selection and Recruitment for Clinical Trials
Collaboration with Clinical Trial Sites
Site Selection for CAR T-cell Trials
The Future of Regulatory Processes in Cell and Gene Therapy
FDA Regulations for CAR T-cell Therapy
Approaching Institutional Biosafety Committee Approval for CAR T-cell Therapy
Key Challenges within CAR T-cell Clinical Trials
The Mission Behind CAR T-cell Clinical Trials
Related Content
An Evolving ‘Opinion’ Landscape: New Paths—and Synergies—for Pharma KOLs & DOLs
October 13th 2023Article
Industry experts discuss the relationship between digital and traditional (key) opinion leaders and how companies are adjusting their strategies to harness the unique brand engagement benefits each role can provide in driving better patient outcomes.
